Drug: Bevacizumab Injury: Myelodysplastic syndrome Quarter: 2016Q3
Total Records: 2 Number of Pages: 1
Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
---|---|---|---|---|---|---|---|---|
126541091 | Bevacizumab | Myelodysplastic syndrome | ROCHE | 60.00 YR | F | 88 KG | 20160816 | US |
127310541 | BEVACIZUMAB | Myelodysplastic syndrome | ACCORD | 55.00 YR | F | 0 | 20160912 | US |
Total Records: 2 Number of Pages: 1